Skip to main content

Exiqon Adds Distributors in Brazil, Eastern Europe

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danish gene expression technologies firm Exiqon today announced two new suppliers for its products in parts of Eastern Europe and Brazil.

Biomedica Medizinprodukte will market Exiqon's life sciences products in the Czech Republic, Slovakia, Slovenia, Croatia, Bosnia & Herzegovina, Serbia, Montenegro, Macedonia, Kosovo, Albania, Poland, Hungary, Romania, and Bulgaria.

Biotik will distribute Exiqon's goods in Brazil, making it Exiqon's first distributor in South America.

"The interest in microRNA research and in our miRCURY LNA product lines continues to grow throughout the world, and these two new distributors will help us address new emerging markets," Elisete Pedrollo, Exiqon's executive vice president of sales and marketing, said in a statement.

The company has 18 distributors in South and Eastern Europe, the Middle East, Brazil, Asia, Australia, and New Zealand.

Financial and other terms of the deals were not disclosed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.